Interesting other facts apart from the MZN vs RXL litigation:
MZN: Mcap $12M Cash $2.7M, 1,327B fps @ 0.9c, postage stamp/pending tenements/advanced uneconomic ZN projects, management with industry/integrity issues and in ground exploration by litigation.
RXL: Mcap $16M Cash $18.2M inc $4M in receivables, 1,236B fps @ 1.3c, prospective mineralized projects, management with credibility/industry awards and ongoing in ground exploration field programs,
One company is either way overvalued or the other is way undervalued, that is respectively in thought.
IMO, MZN is heading to 0.4 – 05c (Mcap $5 – $6.5M, still way overs) with legal debts, NED resignations and a change of management. Opportunities in buying this stock at lower prices will come much sooner than later.
- Forums
- ASX - By Stock
- FFR
- MZN vs RXL litigation
MZN vs RXL litigation
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online